ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

KRM Ayurveda Earnings Call: Key Takeaways

KRM Ayurveda reported FY26 revenue of ₹101.69cr (up 32.8%) and PAT of ₹20.12cr (up 79.4%) following its NSE listing. Strategy shifts toward high-margin services.

Why this was an Alfa AlertNot a filter event. No prior guided range for FY26 metrics was provided for comparison.
Highlights
Revenue growth32.84% YoY for FY26.
MarginsMargins expanded to 30.6% (EBITDA) and 19.8% (PAT).
Demand visibility69% occupancy; 90%+ in established units; high patient references.
Management confidenceStrong; fifth-generation leadership targeting 50% growth.

Growth

Revenue grew 32.84% YoY to ₹101.69cr; EBITDA jumped 62.6% to ₹31.12cr; PAT grew 79.4% to ₹20.12cr.

Outlook

Targeting 50% revenue growth; expanding to 1,500-2,000 beds over 3 years; launching 30+ clinics and luxury Delhi facility.

Risks

Expansion requires significant hiring; managing consistent quality across new pan-India hospital and clinic locations.

Source

Earnings Call filed with NSE, NSE: KRMAYURVED. Summary written with AI assistance from the document.

Read the document ↗

KRM Ayurveda Ltd: key numbers

Share price
₹245.00
Market cap
₹520.9 Cr
Revenue (annual)
₹101.7 Cr
Net profit (annual)
₹20.12 Cr
P/E (TTM)
25.9×Sector 35.3×
Promoter holding
69.30%+0.00% QoQ
FII holding
1.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from KRM Ayurveda Ltd

All →